LogicBio Therapeutics, Inc. Deferred Revenue
LogicBio Therapeutics, Inc. had Deferred Revenue of $8.36 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2022-11-14
- 2022-09-30: Deferred Revenue, Current $8.36M.
- 2022-06-30: Deferred Revenue, Current $10.44M.
- 2022-03-31: Deferred Revenue, Current $8.69M.
- 2021-12-31: Deferred Revenue, Current $10.64M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2022-09-30 | $8.36M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $10.44M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $8.69M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $10.64M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $4.84M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $4.84M 10-Q · filed 2021-08-09 |
| 2020-06-30 | $101.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.06M 10-Q · filed 2020-05-11 |